Skip to main content

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
Cancel
×
×
Home
  • Home
Article
  • Cited by 5
  • Cited by
    Crossref Citations
    Crossref logo
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.
    Colizzi, Marco McGuire, Philip Giampietro, Vincent Williams, Steve Brammer, Mick and Bhattacharyya, Sagnik 2018. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure. European Neuropsychopharmacology, Vol. 28, Issue. 7, p. 850.
    Colizzi, Marco and Bhattacharyya, Sagnik 2018. Cannabis use and the development of tolerance: a systematic review of human evidence. Neuroscience & Biobehavioral Reviews, Vol. 93, Issue. , p. 1.
    Gbyl, Krzysztof and Balslev Jørgensen, Martin 2018. A case of Capgras syndrome and folie à duex in monozygotic twins. Neurocase, Vol. 24, Issue. 3, p. 175.
    Colizzi, Marco and Bhattacharyya, Sagnik 2018. Psychedelic Neuroscience. Vol. 242, Issue. , p. 179.
    Colizzi, Marco Burnett, Natoy Costa, Rosalia De Agostini, Mattia Griffin, James and Bhattacharyya, Sagnik 2018. Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort. Psychiatry Research, Vol. 268, Issue. , p. 381.
    ×
  • Access

Cannabis and psychosis: what do we know and what should we do?

  • Marco Colizzi (a1) and Robin Murray (a2)
Summary

It is now incontrovertible that heavy use of cannabis increases the risk of psychosis. There is a dose–response relationship and high potency preparations and synthetic cannabinoids carry the greatest risk. It would be wise to await the outcome of the different models of legalisation that are being introduced in North America, before deciding whether or not to follow suit.

Declaration of interest

None.

  • View HTML
      • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Cannabis and psychosis: what do we know and what should we do?
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Cannabis and psychosis: what do we know and what should we do?
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Cannabis and psychosis: what do we know and what should we do?
      Available formats
      ×
Copyright
COPYRIGHT: © The Royal College of Psychiatrists 2018 
Corresponding author
Correspondence: Marco Colizzi, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK. Email: marco.v.colizzi@kcl.ac.uk
References
Hide All
1National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. The National Academies Press, 2017.
2Hasin, DS, Sarvet, AL, Cerdá, M, Keyes, KM, Stohl, M, Galea, S, et al. US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013. JAMA Psychiatry 2017; 74: 579–88.
3Hall, W, Lynskey, M. Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction 2016; 111: 1764–73.
4Murray, RM, Englund, A, Abi-Dargham, A, Lewis, DA, Di Forti, M, Davies, C, et al. Cannabis-associated psychosis: neural substrate and clinical impact. Neuropharmacology 2017; 124: 89–104.
5Marconi, A, Di Forti, M, Lewis, CM, Murray, RM, Vassos, E. Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull 2016; 42: 1262–9.
6Colizzi, M, Iyegbe, C, Powell, J, Blasi, G, Bertolino, A, Murray, RM, et al. Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case-control study. NPJ Schizophr 2015; 1: 15025.
7Englund, A, Freeman, TP, Murray, RM, McGuire, P. Can we make cannabis safer? Lancet Psychiatry 2017; 4: 643–8.
8Altintas, M, Inanc, L, Oruc, GA, Arpacioglu, S, Gulec, H. Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients. Neuropsychiatr Dis Treat 2016; 12: 1893–900.
9Schoeler, T, Petros, N, Di Forti, M, Klamerus, E, Foglia, E, Ajnakina, O, et al. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study. Lancet Psychiatry 2016; 3: 947–53.
10Colizzi, M, Carra, E, Fraietta, S, Lally, J, Quattrone, D, Bonaccorso, S, et al. Substance use, medication adherence and outcome one year following a first episode of psychosis. Schizophr Res 2016; 170: 311–7.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *

CAPTCHA *

Skip to the audio challenge
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

  • Cited by 5
  • Cited by
    Crossref Citations
    Crossref logo
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.
    Colizzi, Marco McGuire, Philip Giampietro, Vincent Williams, Steve Brammer, Mick and Bhattacharyya, Sagnik 2018. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure. European Neuropsychopharmacology, Vol. 28, Issue. 7, p. 850.
    Colizzi, Marco and Bhattacharyya, Sagnik 2018. Cannabis use and the development of tolerance: a systematic review of human evidence. Neuroscience & Biobehavioral Reviews, Vol. 93, Issue. , p. 1.
    Gbyl, Krzysztof and Balslev Jørgensen, Martin 2018. A case of Capgras syndrome and folie à duex in monozygotic twins. Neurocase, Vol. 24, Issue. 3, p. 175.
    Colizzi, Marco and Bhattacharyya, Sagnik 2018. Psychedelic Neuroscience. Vol. 242, Issue. , p. 179.
    Colizzi, Marco Burnett, Natoy Costa, Rosalia De Agostini, Mattia Griffin, James and Bhattacharyya, Sagnik 2018. Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort. Psychiatry Research, Vol. 268, Issue. , p. 381.
    ×
  • Access

Cannabis and psychosis: what do we know and what should we do?

  • Marco Colizzi (a1) and Robin Murray (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *

Cancel
Confirm
×